To describe an animal model for acute liver failure by intraperitoneal d-galactosamine injections in rats and to define when is the best time to intervene through King's College and Clichy´s criteria evaluation.
Introduction
Acute liver failure (ALF) is a rare and severe manifestation resulting from sudden and intense hepatocellular necrosis, associated with jaundice, coagulopathy and a certain degree of liver encephalopathy within the first 8 weeks of the appearance of the symptom and the absence of any previous liver condition 1, 2 . This is associated with a high mortality rate of 40-50%, depending on the cause and the therapeutic management 3 .
The etiologies are much varied and the most common are drug intoxication and viral hepatitis 4. Liver presenting acute failure may recover and regenerate, however in most cases the deterioration might be quick for a possible recovery. Currently, in the USA, 45% of the adults have spontaneous recovery and 25% require liver transplant as the only life saving therapy 5 . Early identification in patients who will not survive with support therapy alone is fundamental for indicating liver transplantation. The prognostic evaluation criterion mostly used for this is King's College 6 . Meta-analysis studies have confirmed its specificity (80%), but reported limited sensitivity (70%) 7 .
To overcome this limitation, other prognostic criteria might be used, such as Clichy´s criteria, which takes into consideration the alterations of factor V coagulation, the patient's age and the presence of encephalopathy 8 .
Hepatocytes transplant has been proposed for ALF treatment. In this technique, the human hepatocytes are infused in the splenic vascular, the portal or the peritoneal cavity to provide liver function to the sick liver. Although there are reports of successful errors of congenital metabolism the challenges used in acute liver failure are considerable 9 .
Therefore it becomes highly desirable to have an adequate experimental model for available acute liver failure in order to provide a better understanding of this condition and enables to develop new therapeutic approaches with the aim of extending the survival until the liver transplant takes place or the sick liver regenerates.
In the worldwide literature, the model for inducing acute liver failure via toxins in rats has been mostly used to test support therapies consist of d-galactosamine intraperitoneal administration, because it is potentially reversible, presenting non-significant extra-hepatic toxicity and has the best-defined hepatotoxic dosage 10 .
However, the descriptions of this model are very superficial, thus the reproducibility in other research centers are becoming more difficult. Moreover, studies using d-galactosamine The animals were distributed into the following groups:
Group 1 -Composed of eleven rats were being observed regarding mortality for a period of time, after applied an intraperitoneal d-galactosamine injection of 1.4 g/kg. Craniotomy, thoracotomy and laparotomy were performed after their death, so that the brain, heart, lung, kidneys, spleen, pancreas and liver could be removed for histological analysis.
Group 2 -Composed of 44 rats intraperitoneal
d-galactosamine injection of 1.4 g/kg was applied. After each 12, 24, 48, 72 and 120 hours, six rats were chosen according to the severity criteria of the clinical manifestation presented by each rat. The rats were subjected to intraperitoneal anesthesia using 50 mg/kg of ketamine (Dopalen, Vetbrands Brazil) and 20 mg/kg of xylazine (Virbaxyl 2%, Virbac, Brazil), followed by laparotomy and thoracotomy in order to collect blood by intracardiac puncture until exsanguination and death. After the animals´ death, heart, lung, kidney, spleen, pancreas, and liver were removed for histological analysis. Soon after, craniotomy was performed to remove the brain.
Group 3 -The control group was composed by six rats and were observed for a period of seven days. Then they were anesthetized intraperitoneally by applying 50 mg/kg of ketamine (Dopalen, Vetbrands Brazil) and 20 mg/kg of xylazine (Virbaxyl 2%, Virbac, Brazil) and subjected to laparotomy and thoracotomy in order to collect blood by intracardiac puncture until exsanguination and death. After the animals´ death, heart, lung, kidney, spleen, pancreas, and liver were removed for histological analysis. Soon after, craniotomy was performed to remove the brain. 
D-galactosamine preparation

Intraperitoneal injection
To proceed to the intraperitoneal injection of the drugs, the rats were held with their belly up and with the head slightly inclined downwards in order to move the viscera and intestinal loops toward the diaphragm and to reduce the risk of puncturing.
The rats were weighed and the dose to be administered was calculated with one decimal place and pipette was transferred from the falcon tube to a sterile test tube. The solution was removed by a 5ml syringe coupled to a 22G needle (0.7 x 25mm) and applied in the lower left quadrant of the abdomen. The needle was introduced making an angle of approximately 45° and before injecting the drug, a mild aspiration was performed to be certain that it did not reach the bladder, the intestine or a blood vessel.
Common surgical procedure for all rats
To remove the organs, the rats were anesthetized with 50mg/kg of Ketamine (Dopalen, Vetbrands, Brazil) and 20mg/kg of xylazine (2% Virbaxyl, Virbac, Brazil), applied intraperitoneally, except group 1 which had their organs removed after their death.
The rats were placed in the dorsal decubitus position on the surgical board and had their limbs laid down. Antisepsis containing 70% alcohol was performed previously on the abdominal and thoracic walls and the rats were submitted to laparotomy and thoracotomy of the abdominal wall and thoracic anatomic planes section.
With a 5 ml syringe coupled to a 22G needle (0.7x25mm), a heart puncture was performed to remove blood until the rat died.
The blood was distributed in microsampling tubes (0.5ml for the purple tube EDTA; 0.6ml for the yellow dry tube and 1.8ml for the sodium citrate blue tube) for later analysis, and the rest was discharged.
Liver, spleen, pancreas, right kidney, heart and right lung were removed from the abdominal and thoracic cavity. After the removal of the organs, the abdominal and thoracic walls were closed by stitching.
Subsequently the rat was placed in ventral decubitus position on the surgical board with the limbs laid down and submitted an opening of the skin to expose the cranial followed by a craniotomy and a withdrawal of the brain. The organs were prepared on the surgical board and submitted to thin cuts with a cold bladed scalpel. The cut of each component was placed in a 10% formaldehyde solution in sterilized jars identified with a number for each rat.
Histological analysis
All the rats in this study were subjected to histological analysis of the liver, spleen, pancreas, kidney, heart, lung and brain.
The histological slides were analyzed by the same professional with an optical microscope, blindly, without knowing which slide belonged to which rat.
The semi-quantitatively hepatic histological variables were analyzed, as followed:
• Hepatocellular necrosis: 0-absent; 1-slight (foci of necrosis, sometimes confluent); 2-moderate (extensive areas of confluent necrosis); 3-intense (extensive confluent necrosis as bridge or in panacinar form);
• Apoptosis: 0-absent; 1-slight; 2-moderate; 3-severe;
• Bleeding: 0-No; 1-Yes;
• Steatosis was evaluated regarding the following types: predominantly macrovesicular; or predominantly microvesicular and mixed.
Laboratory analysis
The rats in group 2 were sacrificed at 12, 24, 48, 72 and 120 hours after the intraperitoneal d-galactosamine injection.
Blood samples were collected by intracardiac puncture at a time after applying the anesthesia using ketamine and xylazine. The withdrawal of blood samples from the rats for analysis was also submitted from the control group 3. The following variables were analyzed:
• Aspartate aminotransferase (AST) and alanine aminotransferase (ALT);
• Bilirubin (total and fractions);
• Urea and creatinine;
• Factor V, prothrombin time (PT) and INR;
• Albumin.
Statistical analysis
To compare the numerical laboratory variables of the rats, the Kruskal-Wallis non-parametric test was used because of the small sample size (maximum of 6). Regarding to detect the differences between evaluation times, Dunn-Bonferroni´s multiple comparisons were used to identify such differences.
The existence of the associations between the histological categorical variables was ascertained by using Fisher's exact test because of the small sample size. P values <0.05 were considered statistically significant.
Results
Macroscopic findings
Macroscopically the dead rats´ livers presented a pale coloring ( Figure 1 ) when compared to a normal liver ( Figure 2) and with some hemorrhagic focuses. Hemorrhagic focuses in the lung could also be observed, as well as food stasis in the stomach and intestinal loops. 
Clinical findings and mortality
From observing the rats in group 1, that received doses of 1.4 g/kg of d-galactosamine, was noted that 27 hours after the injection, some rats began to present hemorrhagic suffusions on the tail and nose and, after 49 hours, they presented limb spasms and seizures. Other symptoms presented were restlessness, itching or hyporesponsiveness.
The first death occurred 44 hours after the d-galactosamine injection. The mortality peak occurred between 49 and 60 hours (n = 5). The last death was registered at 76 hours after taking d-galactosamine. 120 hours after applying the injection, three of the eleven rats were still alive (mortality rate of 73%).
In group 2, after 48 hour there were only ten animals alive. So, it was possible to sacrifice only 4 animals at 72h and 120h period.
Laboratory findings
Twelve hours after applying d-galactosamine injection, it was already possible to observe the alterations in the liver enzymes (Table 1 ) and the decrease of the coagulation factors (Table 2 ). The peak for this alteration occurred 24 hours after taking d-galactosamine.
All the laboratory variables studied, presented a statistically significant difference according to Kruskal-Wallis test, except urea (Tables 3 and 4) . Using the Dunn-Bonferroni test to identify the differences, it could be seen that the values reached the variables and were similar at zero hour and at 120 hours after applying the injection, and these were different from the values presented at 24 and 48 hours after applying the injection.
King's College criterion (INR > 6.5) were fulfilled at 12 hours after taking the drug and Clichy´s criterion (Factor V < 30%) was after 24 hours ( Table 2) . 
Microscopic findings
Histological sections through the rats´ livers in group 1 showed extensive areas of confluent necrosis, sometimes compromising zones 1 and 2, accompanied by lymphomononuclear or lymphohistiocytic inflammatory infiltrate, sometimes with the presence of neutrophils. The remaining parenchyma showed ballooned hepatocytes, retraction figures and acidophilus corpuscles, along with slight macro and microvesicular steatosis.
In some rats, slight ductular reaction in zone 1 was observed.
Histological analysis on liver sections over the course of time showed that 12 hours after taking the drug, foci of necrosis and apoptosis could be seen (Figure 3 ). These became more intense after 24 and 48 hours (Figures 4 and 5 ), but then practically normalized after 72 hours ( Figure 6 and Table 5 ). Ballooning and ductular reaction appeared later on, thus suggesting that parenchymal regeneration was occurring (Figure 7) . All histological variables analyzed by Fisher's exact test presented statistically significant differences (Tables 5 and 6 ).
Portal and lobular infiltrates, along with steatosis, could be observed 12 hours after drug administration.
The remaining analyzed organs (lung, heart, kidney, brain, spleen and pancreas) did not present any significant alterations, except for the kidneys of some rats that were sacrificed 48 hours after the d-galactosamine injection. These presented isomeric intracytoplasmic microvacuolation in contorted tubules.
One rat was also sacrificed 48 hours after the injection presented pancreatic steatosis. 
Discussion
Acute liver failure is a severe condition and in liver transplants, most of the time constitutes to as the only life saving therapy. Several animal models for acute liver failure, using rats have been described and the use of d-galactosamine to induce liver failure is the most widely used.
D-galactosamine is an amino sugar metabolized in the liver via galactose, which leads to depletion of uridine nucleotides and blocks the liver transition, thus resulting in massive diffuse necrosis of the liver 11 . Studies using radio labeled d-galactosamine have established the specific hepatotoxicity of this drug: virtually 100% of the drug is metabolized by the liver 12 .
Keppler et al. 13 were among the first researchers to The peak hepatic enzyme alterations coincided with the highest degree of histological liver failure, which occurred 48 hours after the injection, the rats presented second degree of encephalopathy (confusion and numbness). The authors also affirmed that d-galactosamine did not have any direct effect on the bloodbrain barrier, thus suggesting that the brain edema found in the histological analysis was due to a cytotoxic effect that led to the formation of vasogenic edema.
From the analysis on liver failure evolution over the course of time and laboratory alterations in this present study was that the peak for liver enzymes also coincided with the time of greater intensity of necrosis, apoptosis and hepatic bleeding was noted, as Dixit et al. 15 had also observed. However, this peak occurred 24 hours after the d-galactosamine injection, i.e. earlier than what Dixit et al. 15 had observed. One explanation for this is the difference between the doses used in each study, thus, it could be asked whether the evolution of the liver failure is dependent on the dose administered.
Zhang et al. 16 analyzed rats for a period longer than 48
hours. To evaluate the use of granulocytic colony stimulating factor in ALF, 160 Wistar rats were analyzed and subjected to Those authors only analyzed hepatic histology and ALT enzyme alterations. In the group that only received d-galactosamine + saline, the mortality rate was found to be 66.7%
(20/30), i.e. similar to the results in this present study, and the progression of histological lesions through different hours also corresponded to the findings in this present study. However, the peak of ALT and the histological injury found by those authors was at a later stage, occurring 72 hours after the d-galactosamine injection. Reversibility of liver failure was also proven by Zhang et al. 16 showing liver histological sections with regeneration of hepatocytes and vacuolar degeneration five days after the injection, and normal ALT values seven days after the injection.
The group that received granulocytic colony stimulating factor presented a lower mortality of 46.7% (14/30), lower ALT levels and lower liver failure 16 . The intervention was done empirically, without considering any clinical aspects.
D-galactosamine is an expensive drug, and it cannot be applied on large animals and for this reason rats are commonly used, however unfortunately we are not able to get blood samples from the same rat during different periods of time, in which it would be ideal, because of its low blood volume. D-galactosamine is likely to cause irritability to the skin and eyes, it must be handled using personal protection equipment.
The prognosis for acute liver failure improved significantly after the emergency liver transplant has been performing. The oneyear survival rate reached 77%. When evaluating the prognosis for fulminant hepatitis, the decision regarding the need for and the time to proceed a liver transplant should be made as early as possible 17 . A series of prognostic criteria have been developed with the aim to select candidates for a liver transplant the best way possible.
The criterion developed by King's College is the most commonly used. It forms the basis to register for emergency liver transplant in the United Kingdom and has been widely disseminated internationally 8 .
Meta-analysis evaluated the survival among patients with ALF that was not induced by paracetamol showed moderate sensitivity (70%, 95% CI 61-79%) and higher specificity (80%, 95% CI 73-87%), in which the capacity to discriminate between the need for transplant and the lack to need were evaluated by ROC curve, with Q of 0.783 7 . Another meta-analysis performed to evaluate King's College criterion among patients with ALF, secondary to paracetamol, revealed sensitivity of 69% and specificity of 92%, but Q was 0.61 18 . To overcome these limitations, other alternative prognostic systems might be used 6 .
Clichy-Villejuif criteria are mostly used in France, and include hepatic encephalopathy and factor V level < 20% among patients under 30 years of age and < 30% among patients over 30 years of age. Using Clichy´s criteria, a recent study conducted in
France evaluated 808 patients who underwent an emergency liver transplant due to ALF between 1997 and 2010. The sensitivity, specificity and positive and negative predictive values for Clichy´s criteria were 75%, 56%, 50% and 79%, respectively, for ALF due to paracetamol, were 69%, 50%, 64% and 55%, respectively, for ALF unrelated to paracetamol 17 .
Comparing this present study with other similar ones, it was found that this was the first study to evaluate King's College 
